The Near-infrared Imaging Market size was estimated USD 2.0 billion in 2022 and is expected to reach USD 2.6 billion by 2030 at a CAGR of 3.8% during the forecast period of 2023-2030.

The Near-Infrared Imaging Market is poised for significant growth in the coming years, driven by advancements in technology and increasing applications across various industries. Near-infrared imaging refers to the use of near-infrared light to capture images and provide valuable insights into objects or subjects that are otherwise invisible to the naked eye.

One of the key factors driving the market is the growing demand for non-invasive diagnostic techniques in healthcare. Near-infrared imaging offers a safe and efficient way to visualize tissues, blood vessels, and even tumors beneath the skin's surface. It enables early detection of diseases such as cancer, cardiovascular disorders, and neurological conditions, leading to improved patient outcomes.

Get Free PDF Sample Report:

Moreover, near-infrared imaging finds extensive applications in agriculture and food quality control. It helps farmers assess crop health, monitor irrigation levels, detect pests or diseases, and optimize harvest timing. In food processing facilities, near-infrared imaging aids in quality inspection by identifying contaminants or foreign objects that may compromise product safety.

The industrial sector also benefits from near Moreover, near-infrared imaging is widely used in the pharmaceutical industry for various purposes. It plays a crucial role in drug development and quality control by enabling the analysis of chemical compositions and identifying impurities. This technology helps pharmaceutical companies ensure the safety and efficacy of their products, ultimately benefiting patients worldwide. Additionally, near-infrared imaging has proven to be valuable in the field of environmental monitoring. It allows scientists to assess pollution levels, monitor water quality, and detect harmful substances in the environment. By providing accurate and real-time data, near-infrared imaging assists in making informed decisions regarding environmental conservation and protection. Furthermore, the medical field has embraced near-infrared imaging for diagnostic and therapeutic purposes. It enables non-invasive imaging of tissues and organs, aiding in the early detection of diseases such as cancer and cardiovascular conditions. This technology also facilitates targeted drug delivery and monitoring of treatment effectiveness, revolutionizing the way healthcare professionals approach patient care. In conclusion, near-infrared imaging extends its benefits beyond agriculture and food quality control. Its applications in the industrial, pharmaceutical, environmental, and medical sectors have significantly contributed to advancements in various fields, improving safety, efficiency, and overall well-being.


By Product

  • Devices
  • Reagents

In 2022, reagents segment is expected to dominate the near-infrared imaging market share of around 56.8% growth rate during the forecast period due to its offer high sensitivity and precise detection in biological systems, have significant benefits over conventional visible light dyes. Indocyanine Green (ICG) and other reagents are subcategories of reagents. Due to the advantages provided by ICG, the reagents segment is anticipated to increase significantly during the projection period. Angiographic images in real time are provided using indocyanine green during brain tumor or vascular surgery. Additionally, spine surgery is using it more and more. ICG's advantages and expanding applications are hence the segment's main drivers.

By Application

  • Cancer Surgeries
  • Gastrointestinal Surgeries
  • Preclinical Imaging
  • Cardiovascular Surgeries
  • Plastic/Reconstructive Surgeries

In 2022, Preclinical Imaging segment is expected to dominate the near-infrared imaging market share of around 35.1% growth rate during the forecast period owing to the rising prevalence of cancer on a global scale. For example, according to International Agency for Research on Cancer in 2022, there were about 22,874,582 new cancer cases globally, the same source states that the number is expected to reach 50,550,287 by 2025.

By End User

  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Research Laboratories

Major Players Listed in the Report are as Follows:

Quest Medical Imaging B.V., Stryker, KARL STORZ SE & Co. KG, Olympus, Hamamatsu Photonics K.K, Mizuho Medical Co, Ltd., Shimadzu Corporation, Leica Microsystems, Medtronic (Visionsense), PerkinElmer, Inc., Carl Zeiss Meditec, Fluoptics, and Others.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

[email protected],

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)